Metraipolis › archive › dc_72249a647bbe

Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41050705
DOI
10.3389/fimmu.2025.1607138
License (as archived)
solo-consultazione
Archived
2026-11-09T21:14:12.651Z
SHA-256 of the archived text
38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81
Stable URL of this page
https://metraipolis.com/documento/dc_72249a647bbe

How to cite

Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705 — Europe PMC (en), https://europepmc.org/article/MED/41050705 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72249a647bbe (Metraipolis archive dc_72249a647bbe, sha256 38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81)
BibTeX
@misc{dc72249a647bbe,
  title = {Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter… — Europe PMC PMID:41050705},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41050705},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72249a647bbe; sha256 38d110f710406abff9dc1434b9f70b6bd3f239e7ac6083d169ff3ce5ae1b8e81},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050705. Agents can read the archived copy with the MCP tool read_document.